tiprankstipranks
Context Therapeutics (CNTX)
NASDAQ:CNTX
Holding CNTX?
Track your performance easily

Context Therapeutics (CNTX) Financial Statements

89 Followers

Context Therapeutics Financial Overview

Context Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.911; its P/E ratio is -1.65; Context Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.70M$ -3.09M$ -3.82M$ -6.93M$ -6.18M
EBITDA$ -18.70M$ -3.09M$ -3.82M$ -6.93M$ -6.18M
Net Income Common Stockholders$ -17.46M$ -2.25M$ -3.67M$ -6.77M$ -5.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 84.80M$ 101.50M$ 10.10M$ 14.40M$ 21.70M
Total Assets$ 86.33M$ 102.71M$ 11.05M$ 16.06M$ 22.99M
Total Debt$ 244.36K$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -84.56M$ -101.50M$ -10.10M$ -14.40M$ -21.70M
Total Liabilities$ 2.47M$ 1.60M$ 2.61M$ 4.19M$ 4.60M
Stockholders Equity$ 83.86M$ 101.08M$ 8.44M$ 11.87M$ 18.38M
Cash Flow-
Free Cash Flow-$ -3.36M$ -4.36M$ -7.23M$ -3.46M
Operating Cash Flow-$ -3.36M$ -4.36M$ -7.23M$ -3.46M
Investing Cash Flow-----
Financing Cash Flow-$ 94.80M---
Currency in USD

Context Therapeutics Earnings and Revenue History

Context Therapeutics Debt to Assets

Context Therapeutics Cash Flow

Context Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis